Israeli study on 4th shots for COVID is bad news BUT not as bad as it seems

Research dashes hopes that new boosters will deliver Omicron-proof protection, but they may still help the elderly and at-risk by reducing chances of serious illness

6
1067

Fresh details from the world’s first major study on fourth-dose COVID vaccines bode ill — but not as ill as it may seem.

Antibody levels rise significantly after a fourth shot of the Pfizer vaccine, researchers at Sheba Medical Center [Click on the link to conveniently find out more information about the hospital’s treatments, breakthroughs, and advancements] announced on Monday.

“What we see is that after two weeks, the Pfizer vaccine gives an enhancement or increase in the number of antibodies, including neutralizing antibodies,” said Prof. Gili Regev-Yochay, a lead researcher in the experiment, in a press briefing.

There is “a pretty nice increase, even higher than what we had after the third dose,” she said, noting that it had risen a little since she reported last week that the booster gave a fivefold increase, but declining throughout her briefing to give more numbers.

But the rise that she documented “is probably not enough for Omicron,” she lamented, meaning that it won’t deliver highly effective protection against infection by the fast-spreading variant.

As elderly and at-risk Israelis who were the world’s first population to take fourth shots en masse desperately try to understand whether it’s made them safer, it was an answer of sorts — but one that left important questions hanging.

The study is small, with around 150 participants — Sheba employees who received fourth Pfizer shots last month. There were 120 others who received a Moderna shot, after earlier getting three Pfizer shots, and they are building antibodies at a similar rate but are at an earlier stage of the experiment.

Regev-Yochay said there have been some infections among the fourth shot recipients, but her main variable for the study is antibody counts. And what makes her research an important one is that it includes context for what the measurements may mean in Omicron vulnerability.  More…

https://www.timesofisrael.com/israeli-study-on-4th-shots-for-covid-is-bad-news-but-not-as-bad-as-it-seems/

 

ATTENTION READERS
Due to the nature of independent content, VT cannot guarantee content validity.
We ask you to Read Our Content Policy so a clear comprehension of VT's independent non-censored media is understood and given its proper place in the world of news, opinion and media.

All content is owned by author exclusively. Expressed opinions are NOT necessarily the views of VT, other authors, affiliates, advertisers, sponsors, partners or technicians. Some content may be satirical in nature. All images within are full responsibility of author and NOT VT.

About VT - Read Full Policy Notice - Comment Policy

6 COMMENTS

  1. Oh, come on, the solution is simple. Israelis should get a booster every week…that’ll solve all their problems…and ours.

  2. Einstein said stupidity is doing the wrong thing over and over again expecting a different result or something to that effect. How stupid do you people have to be to realize that these “vaxxes” aren’t vaxxes? If they were, not even 1 booster would be necessary, not to mention the countless vaxxed who test positive and develop symptoms continuosly.

    • Yup. Back to basics without the smoke and mirrors. The causal link between administration of multiple live vaccines and short term infant death (SIDS) is enough concern without what the mRNA treatment will do to young developing neurological systems. Ask Uncle Joe Biden. Yeah, right.

  3. Trust nothing from Israel, believe nothing from Israel, only read between the lies….Guys with boxcutters did 9/11, right??

    BDS 2022

  4. Booster #4 will provide 5x the number of antibodies but that will not be very effective against Omicron. Yikes. Pfizer needs to getting working on Super Vaccine. Yeah, that’s what we’ll call it. Run that one by old man Fauci. In any case, we seniors just need to get our affairs in order.

Comments are closed.